Opposing effects of CTLA4-Ig and anti-CD80 (B7-1) plus anti-CD86 (B7-2) on experimental allergic encephalomyelitis

Journal of Neuroimmunology

Volumn 65, Issue 1, 1996, Pages 31-39

  Perrin, Peter J ^a   Scott, Dorothy ^b   Davis, Tiffany A ^a   Gray, Gary S ^c   Doggett, Michael J ^a   Abe, Ryo ^a   June, Carl H ^a   Racke, Michael K ^d  

^a NAVAL MEDICAL RESEARCH INSTITUTE   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^c REPLIGEN CORPORATION   (United States)

^d WASHINGTON UNIVERSITY   (United States)

Author keywords

B7 receptors; CD80; CD86; CTLA 4; Experimental allergic encephalomyelitis; Interferon ; Interleukin 10; Interleukin 2; Tumor necrosis factor

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; ETIOLOGY; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0029921933     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-5728(95)00172-7     Document Type: Article

References (48)

1. Arnason, B.G. (1983) Relevance of experimental allergic encephalomyelitis to multiple sclerosis. Neurol. Clin. 1, 765-782.
2. Azuma, M., Ito, D., Yagita, H., Okumura, K., Phillips, J.H., Lanier, L.L. and Somoza, C. (1993) B70 antigen is a second ligand for CTLA-4 and CD28. Nature 366, 76-79.
3. Baker, D., Butler, D., Scallon, B.J., O'Neill, J.K., Turk, J.L. and Feldmann, M. (1994) Control of established experimental allergic encephalomyelitis by inhibition of tumor necrosis factor (TNF) activity within the central nervous system using monoclonal antibodies and TNF receptor-immunoglobulin fusion proteins. Eur. J. Immunol. 24, 2040-2048.
4. Boussiotis, V.A., Freeman, G.J., Gribben, J.G., Daley, J., Gray, G. and Nadler, L.M. (1993) Activated human B lymphocytes express three CTLA4 counterreceptors that costimulate T-cell activation. Proc. Natl. Acad. Sci. USA 90, 11059-11063.
5. DeBenedette, M.A., Chu, N.R., Pollok, K.E., Hurtado, J., Wade, W.F., Kwon, B.S. and Watts, T.H. (1995) Role of 4-1BB ligand in costimulation of T lymphocyte growth and its upregulation on M12 B lymphomas by cAMP. J. Exp. Med. 181, 985-992.
6. Deibler, G.E., Martenson, R.E. and Kies, M.W. (1972) Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species. Prep. Biochem. 2, 139-165.
7. Finck, B.K., Linsley, P.S. and Wofsy, D. (1994) Treatment of murine lupus with CTLA4-Ig. Science 265, 1225-1227.
8. Freeman, G.J., Gribben, J.G., Boussiotis, V.A., Ng, J.W., Restivo, V.A. Jr., Lombard, L.A., Gray, G.S. and Nadler, L.M. (1993) Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation. Science 262, 909-911.
9. Gimmi, C.D., Freeman, G.J., Gribben, J.G., Gray, G. and Nadler, L.M. (1993) Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation. Proc. Natl. Acad. Sci. USA 90, 6586-6590.
10. Glantz, S.A. (1992) Alternatives to analysis of variance and the t test based on ranks. In: Glantz, S.A. (Ed.) Primer of Biostatistics, 3rd edn. McGraw-Hill, New York, NY.
11. Goodman, R.E., Nestle, F., Naidu, Y.M., Green, J.M., Thompson, C.B., Nickoloff, B.J. and Turka, L.A. (1994) Keratinocyte-derived T cell costimulation induces preferential production of IL-2 and IL-4 but not IFN-gamma. J. Immunol. 152, 5189-5198.
12. Green, J.M., Noel, P.J., Sperling, A.I., Walunas, T.L., Gray, G.S., Bluestone, J.A. and Thompson, C.B. (1994) Absence of B7-dependent responses in Cd28-deficient mice. Immunity 1, 501-508.
13. Guckel, B., Berek, C., Lutz, M., Altevogt, P., Schirrmacher, V. and Kyewski, A. (1991) Anti-CD2 antibodies induce T cell unresponsiveness in vivo. J. Exp. Med. 174, 957-967.
14. Harding, F.A., McArthur, J.G., Gross, J.A., Raulet, D.H. and Allison, J.P. (1992) CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature 356, 607-609.
15. Hathcock, K.S., Laszlo, G., Dickler, H.B., Bradshaw, J., Linsley, P. and Hodes, R.J. (1993) Identification of an alternative CTLA-4 ligand costimulatory for T cell activation. Science 262, 905-907.
16. Isobe, M., Yagita, H., Okumura, K. and Ihara, A. (1992) Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1. Science 255, 1125-1127.
17. June, C.H., Ledbetter, J.A., Linsley, P.S. and Thompson, C.B. (1990) Role of the CD28 receptor in T-cell activation. Immunol. Today 11, 211-216.
18. June, C.H., Bluestone, J.A., Nadler, L.M. and Thompson, C.B. (1994) The B7 and CD28 receptor families. Immunol. Today 15, 321-331.
19. Karpus, W.J., Peterson, J.D. and Miller, S.D. (1994) Anergy in vivo: down-regulation of antigen-specific CD4 + Th1 but not Th2 cytokine responses. Int. Immunol. 6, 721-730.
20. + T cells in vivo is dependent on CD28 costimulation and inhibited by ctla-4. J. Immunol. 155, 1032-1036.
21. Kuchroo, V.K., Das, M.P., Brown, J.A., Ranger, A.M., Zamvil, S.S., Sobel, R.A., Weiner, H.L., Nabavi, N. and Glimcher, L.H. (1995) B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 80, 707-718.
22. Larsen, C.P., Ritchie, S.C., Hendrix, R., Linsley, P.S., Hathcock, K.S., Hodes, R.J., Lowry, R.P. and Pearson, T.C. (1994) Regulation of immunostimulatory function and costimulatory molecule (B7-1 and B7-2) expression on murine dendritic cells. J. Immunol. 152, 5208-5219.
23. Lenschow, D.J., Zeng, Y., Thistlethwaite, J.R., Montag, A., Brady, W., Gibson, M.G., Linsley, P.S. and Bluestone, J.A. (1992) Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4Ig. Science 257, 789-792.
24. Lenschow, D.J., Ho, S.C., Sattar, H., Rhee, L., Gray, G., Nabavi, N., Herold, K.C. and Bluestone, J.A. (1995) Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. J. Exp. Med. 181, 1145-1155.
25. + T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol. Today 16, 34-38.
26. Lin, H., Bolling, S.F., Linsley, P.S., Wei, R.Q., Gordon, D., Thompson, C.B. and Turka, L.A. (1993) Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4Ig plus donor-specific transfusion. J. Exp. Med. 178, 1801-1806.
27. Linsley, P.S., Wallace, P.M., Johnson, J., Gibson, M.G., Greene, J.L., Ledbetter, J.A., Singh, C. and Tepper, M.A. (1992) Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule. Science 257, 792-795.
28. Linsley, P.S., Greene, J.I., Brady, W., Bajorath, J., Ledbetter, J.A. and Peach, R. (1994) Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors. Immunity 1, 793-801.
29. Liu, Y., Jones, B., Aruffo, A., Sullivan, K.M., Linsley, P.S. and Janeway, C.A. Jr. (1992) Heat-stable antigen is a costimulatory molecule for CD4 T cell growth. J. Exp. Med. 175, 437-445.
30. Lu, P., Zhou, X., Chen, S.J., Moorman, M., Morris, S.C., Finkelman, F.D., Linsley, P., Urban, J.F. and Gause, W.C. (1994) CTLA-4 ligands are required to induce an in vivo interleukin 4 response to a gastrointestinal nematode parasite. J. Exp. Med. 180, 693-698.
31. Lucas, P.J., Negishi, I., Nakayama, K., Fields, L.E. and Loh, D.Y. (1995) Naive CD28-deficient T cells can initiate but not sustain an in vitro antigen-specific immune response. J. Immunol. 154, 5757-5768.
32. Martin, R., McFarland, H.F. and McFarlin, D.E. (1992) Immunological aspects of demyelinating diseases. Annu. Rev. Immunol. 10, 153-187.
33. Mokhtarian, F., McFarlin, D.E. and Raine, C.S. (1984) Adoptive transfer of myelin basic protein-sensitized T cells produces chronic relapsing demyelinating disease in mice. Nature 309, 356-358.
34. Morris, S.C., Madden, K.B., Adamovicz, J.J., Gause, W.C., Hubbard, B.R., Gately, M.K. and Finkelman, F.D. (1994) Effects of IL-12 on in vivo cytokine gene expression and Ig isotype selection. J. Immunol. 152, 1047-1056.
35. Perrin, P.J., Scott, D., Quigley, L., Albert, P.S., Feder, O., Gray, G.S., Abe, R., June, C.H. and Racke, M.K. (1995) Role of B7:CD28/CTLA-4 in the induction of chronic relapsing experimental allergic encephalomyelitis. J. Immunol. 154, 1481-1490.
36. Peterson, J.D., Karpus, W.J., Clatch, R.J. and Miller, S.D. (1993) Split tolerance of Th1 and Th2 cells in tolerance to Theiler's murine encephalomyelitis virus. Eur. J. Immunol. 23, 46-55.
37. Pettinelli, C.B., Fritz, R.B., Chou, C.H. and McFarlin, D.E. (1982) Encephalitogenic activity of guinea pig myelin basic protein in the SJL mouse. J. Immunol. 129, 1209-1211.
38. Racke, M.K., Bonomo, A., Scott, D.E., Cannella, B., Levine, A., Raine, C.S., Shevach, E.M. and Rocken, M. (1994) Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J. Exp. Med. 180, 1961-1966.
39. Racke, M.K., Scott, D.E., Quigley, L., Gray, G.S., Abe, R., June, C.H. and Perrin, P.J. (1995) Distinct roles for B7-1 (CD80) and B7-2 (CD86) in the initiation of experimental allergic encephalomyelitis. J. Clin. Invest. 96, 2195-2203.
40. Raine, C.S. (1984) Biology of disease. Analysis of autoimmune demyelination: its impact upon multiple sclerosis. Lab. Invest. 50, 608-635.
41. Razi Wolf, Z., Freeman, G.J., Galvin, F., Benacerraf, B., Nadler, L. and Reiser, H. (1992) Expression and function of the murine B7 antigen, the major costimulatory molecule expressed by peritoneal exudate cells. Proc. Natl. Acad. Sci. USA 89, 4210-4214.
42. Ruddle, N.H., Bergman, C.M., McGrath, K.M., Lingenheld, E.G., Grunnet, M.L., Padula, S.J. and Clark, R.B. (1990) An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. J. Exp. Med. 172, 1193-1200.
43. Sansom, D.M. and Hall, N.D. (1993) B7/BB1, the ligand for CD28, is expressed on repeatedly activated T cells in vitro. Eur. J. Immunol. 23, 295-298.
44. Schwartz, R.H. (1990) A cell culture model for T lymphocyte clonal anergy. Science 248, 1349-1356.
45. + T cells. Annu. Rev. Immunol. 12, 635-673.
46. Selmaj, K., Raine, C.S. and Cross, A.H. (1991) Anti-tumor necrosis factor therapy abrogates autoimmune demyelination. Ann. Neurol. 30, 694-700.
47. Shahinian, A., Pfeffer, K., Lee, K.P., Kundig, T.M., Kishihara, K., Wakeham, A., Kawai, K., Ohashi, P.S., Thompson, C.B. and Mak, T.W. (1993) Differential T cell costimulatory requirements in CD28-deficient mice. Science 261, 609-612.
48. Zamvil, S.S. and Steinman, L. (1990) The T lymphocyte in experimental allergic encephalomyelitis. Annu. Rev. Immunol. 8, 579-621.